Terms: = Thyroid cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Treatment
7 results:
1. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
Peng Y; Fang X; Yao H; Zhang Y; Shi J
Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
[No Abstract] [Full Text] [Related]
2. Long noncoding RNA malat1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract] [Full Text] [Related]
3. Transcript-level regulation of malat1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
[TBL] [Abstract] [Full Text] [Related]
4. Long Non-Coding RNAs in thyroid cancer: Implications for Pathogenesis, Diagnosis, and Therapy.
Mahmoudian-Sani MR; Jalali A; Jamshidi M; Moridi H; Alghasi A; Shojaeian A; Mobini GR
Oncol Res Treat; 2019; 42(3):136-142. PubMed ID: 30799425
[TBL] [Abstract] [Full Text] [Related]
5. thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs.
Hardin H; Helein H; Meyer K; Robertson S; Zhang R; Zhong W; Lloyd RV
Lab Invest; 2018 Sep; 98(9):1133-1142. PubMed ID: 29967342
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA malat1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract] [Full Text] [Related]
7. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell thyroid Neoplasm.
Covach A; Patel S; Hardin H; Lloyd RV
Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
[TBL] [Abstract] [Full Text] [Related]
